Michael Byrnes - 13 May 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Michael Byrnes
Issuer symbol
EFTR on OTC
Transactions as of
13 May 2022
Net transactions value
+$6,476
Form type
4
Filing time
17 May 2022, 20:46:06 UTC
Previous filing
24 Jan 2022
Next filing
07 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $6,476 +4,233 $1.53 4,233 13 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.